Clinical Trial: Intravenous Colistin Versus Intravenous Colistin Plus Nebulized Colistin in VAP Due MDR Acinetobacter Baumannii

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Phase 3b Randomized Double Blind Controled Placebo Comparative Trial of Intravenous Colistin vs Intravenous Colistin Plus Nebulized Colistin in Patients With Ventilator-associated Pneumonia (VAP) Due

Brief Summary: Compare the clinical efficiency evaluated by the treatment of the intravenous colistin plus inhaled colistin opposite to the treatment with colistin intravenous plus inhaled saline solution in patients with VAP due to baumannii carbapenems resistant.

Detailed Summary: Compare the clinical efficiency evaluated by the treatment of the intravenous colistin plus inhaled colistin opposite to the treatment with colistin intravenous plus inhaled saline solution in patients with VAP due to baumannii carbapenems resistant.
Sponsor: Hospitales Universitarios Virgen del Rocío

Current Primary Outcome: Compare the clinical efficiency evaluated by the treatment of the intravenous colistin plus inhaled colistin opposite to the treatment with colistin intravenous plus inhaled saline solution in patients with VAP due to baumannii carbapenems resistant [ Time Frame: 14 days ]

Original Primary Outcome: Compare the clinical efficiency evaluated by the treatment of the intravenous colistin plus inhaled colistin opposite to the treatment with colistin intravenous plus inhaled saline solution in patients with VAP due to baumannii carbapenems resistant

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Hospitales Universitarios Virgen del Rocío

Dates:
Date Received: March 25, 2008
Date Started: April 2008
Date Completion: April 2011
Last Updated: August 3, 2009
Last Verified: August 2009